olmesartan medoxomil-hydrochlorothiazide

Product NDC: 42291-926
Requested package NDC: 42291-926-90
11-digit product format: 422910926
Labeler code: 42291
Product ID: 42291-926_48bfa982-5678-139d-e063-6294a90adbfa
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: olmesartan medoxomil-hydrochlorothiazide
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: AvKARE
Application: NDA021532
Marketing category: NDA
Marketing start: 2023-07-27
Substance: OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
Active strength: 40; 25 mg/1; mg/1
Pharmacologic classes: Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021532-002	BENICAR HCT	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05
N021532-003	BENICAR HCT	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05
N021532-005	BENICAR HCT	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N021532-002	AB
N021532-003	AB
N021532-005	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021532-003	BENICAR HCT	12.5MG;40MG	TABLET / ORAL	AB	RLD	2003-06-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021532-005	BENICAR HCT	25MG;40MG	TABLET / ORAL	AB	RLD, RS	2003-06-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021532-002	BENICAR HCT	12.5MG;20MG	TABLET / ORAL	AB	RLD	2003-06-05	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N021532-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021532-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021532-005	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021532-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021532-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021532-005	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021532-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021532-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021532-005	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021532-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021532-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021532-005	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021532-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021532-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021532-005	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021532-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021532-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021532-005	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021532-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021532-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021532-005	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021532-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021532-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021532-005	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021532-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021532-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021532-005	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021532-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021532-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021532-005	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021532-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021532-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021532-005	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021532-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021532-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021532-005	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021532-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021532-003	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021532-005	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021532-002	AB	1	`301d65b070ca…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: olmesartan medoxomil-hydrochlorothiazide
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
OLMESARTAN MEDOXOMIL	40 mg/1
HYDROCHLOROTHIAZIDE	25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6M97XTV3HD	Internal UNII lookup
0J48LPH2TH	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
403853	Internal RxNorm lookup
403854	Internal RxNorm lookup
403855	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
017bc6a3-5b3d-2381-e063-6394a90abece	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1	Product name	3	20260303
1199f4b7-b537-466c-9a1c-cb09131e9f8b	Product name	1	20251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
b15e9aa6-d523-ca97-480e-570e0543a342	Product name	4	20251024
96816964-c075-ffa7-b7b8-d8570411a3b9	Product name	7	20250305
caadbc51-b731-1a7b-b91a-f7bb4a62554e	Product name	9	20240306
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
162cbc9d-ecc3-72ba-af9f-c76e2756ef54	Product name	3	20221207
9b303cd4-3186-2454-5706-3137e8b2dfd2	Product name	4	20221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
a8e65197-7914-7acf-c7ec-914d53819b34	Product name	3	20190624
8b67f333-47d1-8464-7ce4-406d3dbb295f	Product name	7	20190618
89a57420-ab44-5323-14f9-595159145f9b	Product name	2	20190612
c27b049d-3258-48cf-ebe5-08c236ae78e2	Product name	3	20190610
4a27501f-a987-48a5-99b4-e983d4744d76	Product name	7	20181211
00fc2cf9-672f-3e0b-6afa-43cbc864d058	Product name	4	20180613
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108
a7349398-661d-d9fc-46df-7e128bbd61d9	Product name	5	20171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d	Product name	2	20170719
e0eeb018-194e-4b70-a57d-bac47a97b8ea	Product name	1	20160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502	Product name	2	20150320
ea069444-e874-4c28-833f-d2f52734ef4d	Product name	1	20150206
041df61b-f8b6-48a6-7b67-411e1412678b	Product name	1	20140508
0ad8bdca-888e-00da-648b-6a4de854a167	Product name	1	20140508
433a3439-b8f3-d13a-d2c8-9b221d628d60	Product name	1	20140508
59212689-39e5-a976-6d21-882d76d8079a	Product name	1	20140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212	Product name	1	20140508
78637fb0-95c8-441f-e4b4-db1274b6f956	Product name	1	20140508
df89bd47-2db4-d593-ab37-d11953fd5536	Product name	1	20140508
f151007d-265d-9fbe-857d-1d44f1cb76ba	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
42291-926-90	2024-01-30	C162847	48780-1	1030e365-1f91-111a-e063-dadaa90a10e2	Olmesartan Medoxomil and Hydrochlorothiazide Tablets Rx Only These highlights do not include all the information needed to use Olmesartan Medoxomil and Hydrochlorothiazide safely and effectively. See full prescribing information for Olmesartan Medoxomil and Hydrochlorothiazide. Initial U.S. Approval: 2003

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
42291-926-90	olmesartan medoxomil-hydrochlorothiazide	90 in 1 BOTTLE	TABLET, FILM COATED	90		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42291-926-90	EA - Each	42291-926	189d07ca-c2a5-4bba-89d5-59ad534112fb	1	2023-09-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42291-926	OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE TABLET, FILM COATED [AVKARE]	2	Current NDC, 1 package rows	20230817_017bc6a3-5b3d-2381-e063-6394a90abece.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
olmesartan medoxomil-hydrochlorothiazide	OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE	AvKARE	569596a2-98f0-116a-e063-6294a90a3fa1	2026-07-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021532 application number: NDA021532
Benicar HCT	OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE	Cosette Pharmaceuticals, Inc.	a90915ca-f9d3-4fff-8370-d5dc4cdfc521	2026-03-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021532 application number: NDA021532
olmesartan medoxomil-hydrochlorothiazide	OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE	AvKARE	017bc6a3-5b3d-2381-e063-6394a90abece	2026-01-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021532 application number: NDA021532 ndc (package): 42291-926-90 ndc (product): 42291-926 ndc11 (package): 42291092690
Benicar HCT	OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE	Cosette Pharmaceuticals, Inc.	881a1c32-c209-4038-9c5e-c5e46c6e0546	2023-07-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021532 application number: NDA021532

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6M97XTV3HD	OLMESARTAN MEDOXOMIL	144689-63-4	OLMESARTAN MEDOXOMIL
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
403853	olmesartan medoxomil 20 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	017bc6a3-5b3d-2381-e063-6394a90abece	3
403854	olmesartan medoxomil 40 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	017bc6a3-5b3d-2381-e063-6394a90abece	3
403855	olmesartan medoxomil 40 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	017bc6a3-5b3d-2381-e063-6394a90abece	3
403853	hydrochlorothiazide 12.5 MG / olmesartan medoxomil 20 MG Oral Tablet	SCD	017bc6a3-5b3d-2381-e063-6394a90abece	3
403854	hydrochlorothiazide 12.5 MG / olmesartan medoxomil 40 MG Oral Tablet	SCD	017bc6a3-5b3d-2381-e063-6394a90abece	3
403855	hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet	SCD	017bc6a3-5b3d-2381-e063-6394a90abece	3
403853	HCTZ 12.5 MG / olmesartan medoxomil 20 MG Oral Tablet	SY	017bc6a3-5b3d-2381-e063-6394a90abece	3
403854	HCTZ 12.5 MG / olmesartan medoxomil 40 MG Oral Tablet	SY	017bc6a3-5b3d-2381-e063-6394a90abece	3
403855	HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet	SY	017bc6a3-5b3d-2381-e063-6394a90abece	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
42291-926-90	42291092690	90 TABLET, FILM COATED in 1 BOTTLE (42291-926-90)	2023-07-27	No	No	Current